NMS·Healthcare·$203M·#277 / 520 in Healthcare
MGNX MacroGenics, Inc.
41SPECULATIVE
CATEGORY BREAKDOWN
GROWTH0
QUALITY60
STABILITY28
VALUATION98
GOVERNANCE50
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-0.3%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
75.9%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
8 months
22
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
66.1%
40
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.4x
98
< 3x strong
Rule of 40
Growth rate plus operating margin
-49
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
3.4%
27
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+0.7%
96
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE MGNX WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when MGNX's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.